GSK positive on RSV vaccine for older adults
GSK plc has announced positive headline results from its AReSVi 006 phase III trial. AReSVi…
GSK plc has announced positive headline results from its AReSVi 006 phase III trial. AReSVi…
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has…
Belgian biopharma firm Ziphius Vaccines is set to collaborate with the University of Antwerp to…
New Zealand biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a…
European life sciences venture capital firm Forbion, has announced the first €470M ($500M) close of…
Spanish start-up Cocuus has raised €2.5M ($2.7M) in its pre-Series A funding round. The funds…
Ariceum Therapeutics, a private biotech company developing a radiopharmaceutical product for the diagnosis and systemic…
Biotech investments in Europe jumped in May 2022 with a large initial public offering from…
French biotech contract research organization ProteoGenix, Aseem Healthcare, and life sciences consultancy agency Trident Biopharm…
Danish biotech Synklino has completed a Series A fundraising round that netted €29.8M ($31.8M). The…
United Therapeutics Corporation said it has – in partnership with 3D Systems Corporation – produced…
Dutch biotech company CimCure, which is focusing on the development of vaccine-based cancer immunotherapy, has…